Jon Rowley

By Mary Doolin, Terri Willstaedt, and Jon Rowley Mesenchymal stromal cells (MSCs) are increasingly investigated in preclinical and clinical trials due to their immunomodulatory and regenerative functions, as well as favorable safety profile. The transient transfection of MSCs with genetic material is an invaluable technique that can yield new mechanistic insights into MSC function and improve effectiveness of MSC-based therapies.

Webinar: Mitigating Global Disruptions With Redundancy In Upstream Cell Culture Media Supply Potential delays or shortages in securing critical raw materials can impact production timelines and efficiency — threatening the pharmaceutical industry's ability to meet global health needs. Learn best practices around outsourcing, primary and secondary media supply and how Thermo Fisher is helping ensure consistent Gibco™ media quality and on-time delivery on a global scale. Click here to learn more.

FOCUS ON UPSTREAM MANUFACTURING CFPS use cell lysates or purified enzymes to synthesize proteins. They have emerged as a promising alternative to production with living cells. Exploring Perfusion Technology For Manufacturing Process Intensification Perfusion cell culture technology supports high cell densities and product yields for viral vaccine manufacturing, offering a reliable way to produce high-quality cells at a commercial scale.